Lupin, BLS International Services and Kirloskar Oil Engines to see some action today

03 Apr 2025 Evaluate

Lupin Healthcare (UK), the wholly owned subsidiary Lupin, has acquired Renascience Pharma (Renascience), a UK-based pharmaceutical company and sole supplier of 4 specialty products targeting unmet medical needs in the UK. With this acquisition, Lupin Healthcare (UK) gains full ownership of Renascience which, going forward, will trade as its subsidiary. The portfolio includes branded injectable cephalosporines for infectious diseases, a topical treatment for ear pain and a branded quinazoline-like diuretic for cardiovascular and renal indications.

BLS International FZE, a subsidiary of BLS International Services, has completed the subscription of 99.99% of the share capital of BLS Worldwide Services Inc., a company incorporated under the laws of the Republic of the Philippines. As a result of this subscription, BLS Worldwide Services Inc. is now a Step-Down Subsidiary of the Company (SDS).

Kirloskar Oil Engines has received a prestigious order from Ministry of Defence, Government of India, represented by the Indian Navy for the Design and Development of Medium Speed Marine Diesel Engine of 6MW Capacity under the Make-I scheme.

Royal Orchid Hotels (ROHL) has signed agreement(s) with Karnataka State Tourism Development Corporation (KSTDC) for renewal of Land Lease Deed of Hotel Royal Orchid, Bengaluru for a period of 29 years and 6 months.

Popular Vehicles & Services has opened a state-of-the-art 3S facility (Showroom, Service, and Spare Parts) for Maruti Suzuki in Bangalore, Karnataka. This marks the company’s entry into the Karnataka market. Strategically located in Avalahalli, Bangalore, this integrated facility brings together a showroom, workshop, and pre-owned car business under one roof. Spanning 5,000 sq. ft. for the showroom area and 10,000 sq. ft. for the service area with 20 bays, the facility represents a total investment of approximately Rs 9 crore.

Piramal Pharma has commenced commercial production of Sevoflurane at the company’s facility located at Digwal, Telangana, India. This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility in addition to existing capabilities at the company’s facility at Bethlehem, Pennsylvania, USA. This would boost the company’s capability to also tap into inhalation anesthesia opportunities in the ROW markets in addition to the USA markets.

Avantel has secured purchase order worth of Rs 4.96 crore (Excl. Taxes) from Department of Atomic Energy. The said order is to be executed by May 02, 2026. Earlier, the company had received a purchase order worth of Rs 11.36 crore (Incl. Taxes) for supply of satcom systems from M/s Goa Shipyard.

Caplin Point Laboratories’ subsidiary -- Caplin Point Far East has acquired Neoethicals Chile SpA. The company’s subsidiary has acquired 3000 equity shares of Neoethicals Chile SpA at the face value of One Thousand Chilean Peso per share (equivalent to $3000). Recently, the Caplin Point Far East’s board had approved the investment in Neoethicals Chile SpA through the purchase of all its shares.

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.